Max Chat
Relief Therapeutics Holding AG
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 54.24 | -100% | 0 | 0% |
| P/S |
|
6.29 | 4.62 | 36.17% |
|
|
| P/BV |
|
1.44 | 4.2 | -65.58% |
|
|
| P/FCF |
|
-10.04 | 16.2 | -161.97% |
|
|
| Ev/Ebitda |
|
-0.26 | 14.71 | -101.77% |
|
|
| Ev/S |
|
1.54 | 4.05 | -61.88% |
|
|
| Ev/FCF |
|
-4.21 | 20.97 | -120.07% |
|
|
| E/P |
|
-0.5522 | 1.63 | -133.95% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-674.82 | 25.2 | -2777.97% | -637.6 | +5.84% |
| ROE |
|
-38.52 | 12.46 | -409.02% |
|
|
| ROA |
|
-26.42 | 6.23 | -523.89% |
|
|
| ROIC |
|
0 | 15.34 | -100% |
|
|
| ROS |
|
-203.39 | 12.71 | -1700.32% |
|
|
| ROCE |
|
0 | 14.68 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0061 | 6.22 | -100.1% | -0.0221 | -72.4% |
| Nеt Debt/Ebitda |
|
0 | -3.47 | -100% |
|
|
| Debt/Ratio |
|
0.0065 | 0.2246 | -97.11% |
|
|
| Debt/Equity |
|
0.4517 | 1 | -54.9% |
|
|
| Debt/Net Income |
|
-0.0202 | 18.36 | -100.11% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 2.28 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.59 | -100% | ||
| DSI |
|
0 | 0.7935 | -100% |
|
|
| Average dividend growth |
|
0 | -303.64 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 2.59 | -100% |
|
|
| Average percentage for payments |
|
0 | 167.32 | -100% |
|
|
| Difference from average difference in sector |
|
-2.28 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1389.73 | -98.5 | -1510.89% | ||
| Growth impulse Ebitda in 5 years |
|
19320.85 | -98.62 | -19691.21% | ||
| Growth impulse Net Income in 5 years |
|
118.69 | -98.32 | -220.72% | ||
| Growth impulse FCF in 5 years |
|
-83.08 | -98.32 | -15.5% | ||
| Growth impulse EPS in 5 years |
|
19401.48 | -82.03 | -23751.69% |
IP Score
4.55/10
